Royce Capital Small-Cap Portfolio FY 2025: What Worked

Royce Capital Small-Cap Portfolio returned +8.9% in 2025 versus a +12.6% gain for the small-cap value index, an underperformance of 370 basis points. Seven of the portfolio's 10 equity sectors contributed positively to calendar-year performance, while two of the fund's top five contributors are electronics contract manufacturers (EMS), indicating concentration in EMS exposure despite overall sector breadth.

Analysis

EMS providers sit at a structural intersection of cyclical electronics demand and a multi-year shift toward higher-content applications (EV powertrains, industrial automation, advanced telecom). That combination compresses the usual revenue volatility: orderbooks still exhibit seasonality, but average selling prices and per-unit content have been rising ~5-10% annually in industrial/auto segments, which can lift gross margins by several hundred basis points versus commodity consumer builds. The second-order winners are test-and-assembly OSATs and mid-tier passive/component suppliers whose lead times shorten the reorder cycle; losers are low-margin consumer-focused contract manufacturers and distributors that are first hit during inventory digestion.

Key reversal risks are classic inventory-cycle and demand shocks: a China consumer slowdown, a sudden smartphone refresh lull, or a 10-20% semiconductor demand pullback could compress EMS free cash flow within 3-6 months and trigger valuation multiple contraction. Watch leading indicators — book-to-bill, days inventory, OEM capex guidance, and semiconductor billings — for month-over-month inflection. Over a 12–24 month horizon, policy-driven reshoring and higher content per vehicle/industrial machine provide a tailwind that could sustainably re-rate high-quality EMS names if orders prove durable.

Given the current cautious investor tone and mildly negative positioning, there’s asymmetric opportunity in concentrated, higher-quality EMS exposure versus broad small-cap value baskets. Active managers can outperform if they rotate into EMS names before consensus recognizes margin expansion beyond the next quarter. The trade-off is clear: capture multi-quarter structural re-rating while protecting against near-term inventory rebalancing via pairs and option structures.

Key Decisions for Investors

• Long FLEX (FLEX) — buy shares or a 9–12 month 1x2 call spread (long ATM call, sell 2 OTM calls at ~30% upside). Timeframe: 6–12 months. R/R: target 35–50% upside if book-to-bill inflects positive; downside capped to ~25% on spread-funded basis if cyclical demand weakens.
• Pair trade: Long Jabil (JBL) / Short Russell 2000 Value ETF (IWN) — equal dollar exposure. Timeframe: 3–9 months. R/R: aim for 20–35% relative outperformance; stop-loss if pair moves against by 8–10% to limit drawdown from macro-driven market reversals.
• Long Sanmina (SANM) — buy shares with a 12-month horizon, size as a conviction smaller-cap allocation. R/R: high convexity to orderbook recovery and industrial/medical wins; concentration risk if major customer softness appears — set stop at 20%.
• Tactical hedge: buy 3–6 month put spreads on IWN (buy 1 OTM put, sell deeper OTM put) to protect overall small-cap value exposure while maintaining carry. Timeframe: 3 months. R/R: limited cost protection against a sharp small-cap value correction driven by macro or inventory shocks.